BRIVARACETAM
AUROBINDO PHARMA · BRIVARACETAM
Open FDA's page for this record- Application number
- ANDA220288
- Sponsor name
- AUROBINDO PHARMA
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260810
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- BRIVARACETAM
- Reference standard
- No
- Dosage form
- SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AA
- Active ingredients
- Name
- BRIVARACETAM
- Strength
- 10MG/ML
- Harmonized identifiers (openFDA)
- Application number
- ANDA220288
- Brand name
- BRIVARACETAM
- Generic name
- BRIVARACETAM
- Manufacturer name
- Aurobindo Pharma Limited
- Product NDC
- 59651-995
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- BRIVARACETAM
- RxCUI
- 1739785
- SPL ID
- bd0525ad-75ee-4870-8e88-db05b3aae880
- SPL set ID
- 57cfb2c3-395d-0892-e063-6294a90a1064
- Package NDC
- 59651-995-03
- Nui
- N0000192345
- Pharm class moa
- Epoxide Hydrolase Inhibitors [MoA]
- UNII
- U863JGG2IA
